James Samuel Shannon, Director at Horizon Therapeutics Public Ltd Co (HZNP), sold 15,500 shares at $26.59 ($412K) on 2019-09-12, disclosed to the SEC on 2019-09-13.
Open-market sale of $412k HZNP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HZNP | SELL | 2021-03-03 | $1.3M | — | Filing → |
| HZNP | SELL | 2019-09-13 | $661K | — | Filing → |